Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors

被引:35
作者
Sakamoto, N
Terai, T
Ajioka, Y
Abe, S
Kobayasi, O
Hirai, S
Hino, O
Watanabe, H
Sato, N
Shimoda, T
Fujii, H
机构
[1] Juntendo Univ, Sch Med, Dept Pathol 2, Tokyo 1138421, Japan
[2] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 1138421, Japan
[3] Niigata Univ, Grad Sch Med & Dent Sci, Course Mol & Cellular Med, Dept Mol Genet,Div Mol & Cellular Med, Niigata 9518514, Japan
[4] Tokyo Rinkai Hosp, Div Pathol, Tokyo, Japan
[5] Japanese Fdn Canc Res, Inst Canc, Dept Expt Pathol, Tokyo 170, Japan
[6] Natl Canc Ctr, Res Inst & Hosp, Div Pathol, Tokyo 104, Japan
[7] Natl Canc Ctr, Res Inst & Hosp, Div Clin Lab, Tokyo 104, Japan
关键词
flat-type colorectal tumor; RASSF1A; 3p LOH; K-ras; tumor suppressor gene; methylation;
D O I
10.1038/sj.onc.1207993
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Flat colorectal tumors, characterized by high-grade dysplasia from early small. at mucosal lesions, exhibit a relatively aggressive clinical behavior and are known for their infrequent K-ras mutations. In this study, we investigated the methylation status of the RASSF1A promoter in association with 3p LOH and K-ras mutations in 48. at colorectal tumors (39 early carcinomas and nine intramucosal high-grade dysplasias). RASSF1A hypermethylation was detected in 39 of 48 (81.3%) tumors and RASSF1A methylation was also detected in 19 of 39 (49%) normal colonic mucosal tissues. 3p21.3 LOH was detected in 20 of 42 (47.6%) cases, but RASSF1 methylation was detected in cases with LOH (14 cases) and retention of 3p21.3 ( 20 cases). K-ras mutations were detected in seven of 48 (14.6%) tumors and the concordant occurrence of K-ras mutation and RASSF1A methylation was detected in three of 48 cases (6.3%). Overall, there was a statistically significant mutually exclusive relationship between K-ras mutations and RASSF1A methylation. In conclusion, promoter hypermethylation of RASSF1A is a frequent event and may start early in the background normal mucosa in this tumor type. An alternative cascade of abnormalities in RAS transduction pathways may be responsible for the. at morphology and aggressive nature of. at colorectal neoplasms.
引用
收藏
页码:8900 / 8907
页数:8
相关论文
共 48 条
[1]   Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours [J].
Agathanggelou, A ;
Honorio, S ;
Macartney, DP ;
Martinez, A ;
Dallol, A ;
Radar, J ;
Fullwood, P ;
Chauhan, A ;
Walker, R ;
Shaw, JA ;
Hosoe, S ;
Lerman, MI ;
Minna, JD ;
Maher, ER ;
Latif, F .
ONCOGENE, 2001, 20 (12) :1509-1518
[2]   Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression [J].
Burbee, DG ;
Forgacs, E ;
Zöchbauer-Müller, S ;
Shivakumar, L ;
Fong, K ;
Gao, BN ;
Randle, D ;
Kondo, M ;
Virmani, A ;
Bader, S ;
Sekido, Y ;
Latif, F ;
Milchgrub, S ;
Toyooka, S ;
Gazdar, AF ;
Lerman, MI ;
Zabarovsky, E ;
White, M ;
Minna, JD .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (09) :691-699
[3]  
Byun DS, 2001, CANCER RES, V61, P7034
[4]   H2AX haploinsufficiency modifies genomic stability and tumor susceptibility [J].
Celeste, A ;
Difilippantonio, S ;
Difilippantonio, MJ ;
Fernandez-Capetillo, O ;
Pilch, DR ;
Sedelnikova, OA ;
Eckhaus, M ;
Ried, T ;
Bonner, WM ;
Nussenzweig, A .
CELL, 2003, 114 (03) :371-383
[5]  
Chiang JM, 1998, CANCER RES, V58, P3289
[6]   Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma [J].
Dammann, R ;
Schagdarsurengin, U ;
Liu, LM ;
Otto, N ;
Gimm, O ;
Dralle, H ;
Boehm, B ;
Pfeifer, GP ;
Hoang-Vu, C .
ONCOGENE, 2003, 22 (24) :3806-3812
[7]   Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 [J].
Dammann, R ;
Li, C ;
Yoon, JH ;
Chin, PL ;
Bates, S ;
Pfeifer, GP .
NATURE GENETICS, 2000, 25 (03) :315-319
[8]  
Dammann R, 2003, HISTOL HISTOPATHOL, V18, P665, DOI 10.14670/HH-18.665
[9]   The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas [J].
Dammann, R ;
Takahashi, T ;
Pfeifer, GP .
ONCOGENE, 2001, 20 (27) :3563-3567
[10]  
FENOGLIO CM, 1974, CANCER, V34, P819, DOI 10.1002/1097-0142(197409)34:3+<819::AID-CNCR2820340706>3.0.CO